A bypass for the Institutional Review Board: Reflections on the Cleveland Clinic study of the Batista operation

      When I heard the oral presentation of the study of the Batista operation conducted by Patrick McCarthy and his colleagues last May, I shared in the thrill that was palpable in the audience. Chosen by the program committee as one of the first presentations at the meeting of The American Association for Thoracic Surgery, the study delivered a clear and practical surgical judgment about the validity of left ventricular reduction, a new procedure widely regarded as radically innovative.
      To read this article in full you will need to make a payment


        • Engelhardt Jr., HT
        The foundations of bioethics.
        in: 2nd ed. Oxford University Press, New York1996: 3-31
        • Levine RJ.
        Ethics and regulation of clinical research.
        in: 2nd ed. Yale University Press, New Haven1988: 4-5 (127-30)
        • McKneally MF.
        Ethical problems in surgery: innovation leading to unforeseen complications.
        World J Surg. 1999; 23: 786-788
        • World Medical Association's Declaration of Helsinki
        Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects.
        JAMA. 1997; 277 (available online at): 925-926
        • Abernathy CM
        • Hamm RM.
        Surgical intuition: What it is and how to get it.
        in: Hanley & Belfus, Philadelphia1995: 23-27

      Linked Article

      • Partial left ventriculectomy for dilated cardiomyopathy: Is this an alternative to transplantation?
        The Journal of Thoracic and Cardiovascular SurgeryVol. 121Issue 5
        • Preview
          Objective: To determine the late effectiveness of partial left ventriculectomy and risk factors for failure. Methods: Between May 1996 and December 1998, partial left ventriculectomy and concomitant mitral valve surgery were performed in 62 patients (95% transplant candidates) with a mean age of 54 years (range 17-72 years). All patients were in New York Heart Association functional class III (38%) or IV (62%) because of idiopathic dilated cardiomyopathy (59 patients) or ischemic, valvular, or familial cardiomyopathy (1 patient each).
        • Full-Text
        • PDF